Results for tag: "Sufugolix"

Sufugolix is a drug used to treat endocrine and metabolic disorders. It is a gonadotropin-releasing hormone (GnRH) antagonist, which works by blocking the action of GnRH, a hormone that stimulates the release of other hormones. This helps to reduce the production of hormones that can cause endocrine and metabolic disorders. Sufugolix is used to treat conditions such as polycystic ovary syndrome, precocious puberty, and prostate cancer. The Sufugolix market is composed of a variety of companies that develop, manufacture, and market the drug. These companies include AbbVie, Astellas Pharma, and Eisai. Other companies involved in the Sufugolix market include Daiichi Sankyo, Merck, and Pfizer. These companies are involved in the research, development, and marketing of the drug, as well as providing support services to healthcare professionals and patients. Show Less Read more